Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
Laurenti
Luca
L
Istituto di Ematologia, Università Cattolica del Sacro Cuore, Rome, Italy.
Tarnani
Michela
M
Innocenti
Idanna
I
Savino
Gustavo
G
Battendieri
Remo
R
Larocca
Luigi Maria
LM
Chiusolo
Patrizia
P
Sorà
Federica
F
Sica
Simona
S
Efremov
Dimitar
D
Leone
Giuseppe
G
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005142:Eyelid Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab